[The metabolic effects of beta-receptor blockers. What is of practical importance in antihypertensive therapy?].
Sawicki
P T
PT
Abteilung für Ernährung und Stoffwechsel, Universität Düsseldorf.
Berger
M
M
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000378:metabolism; D005951:Glucose Tolerance Test; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000378:metabolism*; D007333:Insulin Resistance; D008055:Lipids / Q000097:blood; D011943:Receptors, Adrenergic, beta / Q000187:drug effects / Q000378:metabolism
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D008055:Lipids; D011943:Receptors, Adrenergic, beta
Metabolische Wirkungen von beta-Rezeptorenblockern. Was ist praktisch wichtig bei der antihypertensiven Therapie?